Cipher Pharmaceuticals

Cipher Pharmaceuticals EBIT per Share

The EBIT per Share of Cipher Pharmaceuticals (CPH.TO) as of Oct 27, 2026 is 0.65 USD. In the previous year, EBIT per Share was 0.32 USD — a change of 102.29% (higher).

EBIT per Share

0.65USD

YoY

102.29%

Last updated:

EBIT per Share of Cipher Pharmaceuticals is 2025 0.65 USD. EBIT per Share of Cipher Pharmaceuticals was 2024 0.32 USD. It decreases by 102.29% higher compared to the previous year.

The Cipher Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
0.45 USD
Jan 1, 2024
0.32 USD
Jan 1, 2025
0.65 USD
Jan 1, 2026 (e)
0.84 USD
Jan 1, 2027 (e)
0.91 USD
Jan 1, 2028 (e)
0.96 USD
Jan 1, 2029 (e)
1.17 USD
Jan 1, 2030 (e)
1.27 USD
The Cipher Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
est1.27USD+8.00%
est1.17USD+21.63%
est0.96USD+6.03%
est0.91USD+8.71%
est0.84USD+29.45%
0.65USD+102.29%
0.32USD-29.30%
0.45USD-3.97%
0.47USD+6.79%
0.44USD-2.28%
0.45USD+4.41%
0.43USD+119.16%
0.20USD-78.88%
0.93USD+263.97%
0.26USD-10,298.53%
-0.00USD-98.59%
-0.18USD-128.30%
0.63USD+610.14%
0.09USD-202.16%
-0.09USD+23,410.13%
-0.00USD-99.63%
-0.10USD-14.56%
-0.12USD-56.70%
-0.27USD-29.18%
-0.38USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cipher Pharmaceuticals Stock analysis

What does Cipher Pharmaceuticals do? Cipher Pharmaceuticals Inc. is a Canadian pharmaceutical company specializing in the development, marketing, and distribution of medications. The company was founded in 1999 and is headquartered in Oakville, Ontario, Canada. Translator note: The translation provided above is a faithful rendering of the German text into English. Cipher Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cipher Pharmaceuticals stock

EBIT per Share of Cipher Pharmaceuticals is 0.65 USD in 2025.

EBIT per Share of Cipher Pharmaceuticals changed from 0.32 USD to 0.65 USD, representing a 102.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cipher Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cipher Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cipher Pharmaceuticals